Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2022
DOI: 10.1038/s41589-022-01151-y
|View full text |Cite
|
Sign up to set email alerts
|

Targeting androgen receptor phase separation to overcome antiandrogen resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
48
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 66 publications
(67 citation statements)
references
References 55 publications
4
48
1
Order By: Relevance
“…1A). In agreement with recent findings 20 , we found that in transiently transfected HEK293T cells, both the full-length AR and the AR-V7 splice variant, that contain the AD and DBD, displayed the capacity to form nuclear clusters, but the DBD alone did not (Fig. 1B).…”
Section: Resultssupporting
confidence: 93%
See 3 more Smart Citations
“…1A). In agreement with recent findings 20 , we found that in transiently transfected HEK293T cells, both the full-length AR and the AR-V7 splice variant, that contain the AD and DBD, displayed the capacity to form nuclear clusters, but the DBD alone did not (Fig. 1B).…”
Section: Resultssupporting
confidence: 93%
“…Consistent with the in vitro data, eGFP-AR-ΔNLS that lacks the 23 FQNLF 27 motif formed fewer and smaller condensates in PC3 cells (Supplementary Fig. 4I-K), in agreement with recent reports 20 . These results collectively suggest that at least three interactions play key roles in phase separation of the hormone-exposed androgen receptor: i) interaction between the LBD and AD that requires helix formation by the 23 FQNLF 27 motif, ii) aromatic residues especially around the short helical regions in the Tau-5 sub-domain of the AD, and iii) the previously described dimerization interface in the LBD 51 (Fig.…”
Section: Short Unstable Helices Enhance Ar Phase Separationsupporting
confidence: 92%
See 2 more Smart Citations
“…ETS-001 binds to the enzyme, blocking condensate formation and stifling the tumour. Last month, Zhu and his collaborators described another drug candidate for prostate cancer that disrupts condensates that are thought to make such cancers resistant to certain standard therapies 12 .…”
Section: Drugging Dropletsmentioning
confidence: 99%